Cite
HARVARD Citation
Heidegger, I. et al. (2022). Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review. Therapeutic advances in medical oncology. p. . [Online].